The global human growth hormone market was valued at $2,840.70 million in 2018 and is expected to reach $5,563.60 million by 2026, registering a CAGR of 8.6% from 2019 to 2026. Human growth hormone is a protein made by the pituitary gland and is secreted into the bloodstream to other parts of the body. Its production is regulated by an intricate set of hormones produced in the hypothalamus gland, intestinal tract, and pancreas. Further, these hormones act on several tissues throughout the body. In adolescents, it stimulates the growth of bone and cartilage. Whereas in adults, it boosts protein production, promotes the utilization of fat, interferes with the action of insulin, and raises blood sugar levels. GH also raises levels of insulin-like growth factor1.
Surge in awareness regarding the effectiveness of growth hormones and increase in prevalence of chronic diseases including growth retardation and pituitary dysfunctions and surge in compliance for growth hormone formulations are the major factors that drive the growth of the global human growth hormone market.
However, the side effects associated with its vigorous usage such as muscle pain, joint pain, and fluid retention and high cost of the treatment hampers the growth of the market. Moreover, stringent government approvals are expected to restrain the growth and development of the market in the coming years. Furthermore, rise in disposable income and surge in healthcare expenditure in developing economies is anticipated to create lucrative growth opportunities for the market.
The human growth hormone market can be segmented on the basis of application, route of administration, distribution channel, and region. By application, it is categorized into growth hormone deficiency, Prader-Willi syndrome, Turner syndrome, and small for gestational age, and others . By route of administration, it is classified into intravenous, intramuscular, subcutaneous, and oral. On the basis of distribution channel, it is divided into hospital pharmacy, retail pharmacy, clinic, and online pharmacy. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
ü The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
ü It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
ü Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
ü Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Application
• Growth Hormone Deficiency
• Prader-Willi Syndrome
• Turner Syndrome
• Small for Gestational Age
• Others
By Route of Administration
• Intravenous
• Intramuscular
• Subcutaneous
• Oral
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Pharmacy
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS
• Novo Nordisk
• Merck & Co., Inc
• Eli Lilly and Company
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd
• Novartis AG
• AnkeBio Co. Ltd
• F. Hoffmann-La Roche
• Ipsen
• Ferring B.V.
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Porter'S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase In Usage Of Growth Hormone To Control Aging
3.4.1.2. Surge In Disorders Related To Growth Hormone Deficiency
3.4.2. Restraints
3.4.2.1. Side Effects Associated With The Treatment
3.4.3. Opportunities
3.4.3.1. Rise In Awareness Towards Usage Of Human Growth In Developing Economies
Chapter 4: Human Growth Hormone Market, By Application
4.1. Overview
4.1.1. Market Size And Forecast, By Application
4.2. Growth Hormone Deficiency
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Prader-Willi Syndrome
4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Turner Syndrome
4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
4.5. Small For Gestational Age (Sga)
4.5.1. Key Market Trends And Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis, By Country
4.6. Others
4.6.1. Key Market Trends And Opportunities
4.6.2. Market Size And Forecast, By Region
4.6.3. Market Analysis, By Country
Chapter 5: Human Growth Hormone Market, By Route Of Administration
5.1. Overview
5.1.1. Market Size And Forecast, By Application
5.2. Oral
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
5.3. Intravenous
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
5.4. Intramuscular
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country
5.5. Subcutaneous
5.5.1. Market Size And Forecast, By Region
5.5.2. Market Analysis, By Country
Chapter 6: Human Growth Hormone Market, Distribution Channel
6.1. Overview
6.1.1. Market Size And Forecast, Distribution Channel
6.2. Hospital Pharmacy
6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis, By Country
6.3. Retail Pharmacy
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis, By Country
6.4. Online Pharmacy
6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis, By Country
Chapter 7: Human Growth Hormone Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends And Opportunities
7.2.2. Market Size And Forecast, By Application
7.2.3. Market Size And Forecast, By Route Of Administration
7.2.4. Market Size And Forecast, Distribution Channel
7.2.4.1. U.S. Market Size And Forecast, By Application
7.2.4.2. U.S. Market Size And Forecast, By Route Of Administration
7.2.4.3. U.S. Market Size And Forecast, Distribution Channel
7.2.4.4. Canada Market Size And Forecast, By Application
7.2.4.5. Canada Market Size And Forecast, By Route Of Administration
7.2.4.6. Canada Market Size And Forecast, Distribution Channel
7.2.4.7. Mexico Market Size And Forecast, By Application
7.2.4.8. Mexico Market Size And Forecast, By Route Of Administration
7.2.4.9. Mexico Market Size And Forecast, Distribution Channel
7.3. Europe
7.3.1. Key Market Trends And Opportunities
7.3.2. Europe Market Size And Forecast, By Application
7.3.3. Europe Market Size And Forecast, By Route Of Administration
7.3.4. Europe Market Size And Forecast, Distribution Channel
7.3.5. Europe Market Size And Forecast, By Country
7.3.5.1. France Market Size And Forecast, By Application
7.3.5.2. France Market Size And Forecast, By Route Of Administration
7.3.5.3. France Market Size And Forecast, Distribution Channel
7.3.5.4. Uk Market Size And Forecast, By Application
7.3.5.5. Uk Market Size And Forecast, By Route Of Administration
7.3.5.6. Uk Market Size And Forecast, Distribution Channel
7.3.5.7. Germany Market Size And Forecast, By Application
7.3.5.8. Germany Market Size And Forecast, By Route Of Administration
7.3.5.9. Germany Market Size And Forecast, Distribution Channel
7.3.5.10. Spain Market Size And Forecast, By Application
7.3.5.11. Spain Market Size And Forecast, By Route Of Administration
7.3.5.12. Spain Market Size And Forecast, Distribution Channel
7.3.5.13. Rest Of Europe Market Size And Forecast, By Application
7.3.5.14. Rest Of Europe Market Size And Forecast, By Route Of Administration
7.3.5.15. Rest Of Europe Market Size And Forecast, Distribution Channel
7.4. Asia-Pacific
7.4.1. Key Market Trends And Opportunities
7.4.2. Asia-Pacific Market Size And Forecast, By Application
7.4.3. Asia-Pacific Market Size And Forecast, By Route Of Administration
7.4.4. Asia-Pacific Market Size And Forecast, Distribution Channel
7.4.5. Asia-Pacific Market Size And Forecast, By Country
7.4.5.1. Japan Market Size And Forecast, By Application
7.4.5.2. Japan Market Size And Forecast, By Route Of Administration
7.4.5.3. Japan Market Size And Forecast, Distribution Channel
7.4.5.4. China Market Size And Forecast, By Application
7.4.5.5. China Market Size And Forecast, By Route Of Administration
7.4.5.6. China Market Size And Forecast, Distribution Channel
7.4.5.7. India Market Size And Forecast, By Application
7.4.5.8. India Market Size And Forecast, By Route Of Administration
7.4.5.9. India Market Size And Forecast, Distribution Channel
7.4.5.10. Australia Market Size And Forecast, By Application
7.4.5.11. Australia Market Size And Forecast, By Application
7.4.5.12. Australia Market Size And Forecast, Distribution Channel
7.4.5.13. Rest Of Asia-Pacific Market Size And Forecast, By Application
7.4.5.14. Rest Of Asia-Pacific Market Size And Forecast, By Route Of Administration
7.4.5.15. Rest Of Asia-Pacific Market Size And Forecast, Distribution Channel
7.5. Lamea
7.5.1. Key Market Trends And Opportunities
7.5.2. Lamea Market Size And Forecast, By Application
7.5.3. Lamea Market Size And Forecast, By Route Of Administration
7.5.4. Lamea Market Size And Forecast, Distribution Channel
7.5.5. Lamea Market Size And Forecast, By Country
7.5.5.1. Brazil Market Size And Forecast, By Application
7.5.5.2. Brazil Market Size And Forecast, By Route Of Administration
7.5.5.3. Brazil Market Size And Forecast, Distribution Channel
7.5.5.4. Saudi Arabia Market Size And Forecast, By Application
7.5.5.5. Saudi Arabia Market Size And Forecast, By Route Of Administration
7.5.5.6. Saudi Arabia Market Size And Forecast, Distribution Channel
7.5.5.7. South Africa Market Size And Forecast, By Application
7.5.5.8. South Africa Market Size And Forecast, By Route Of Administration
7.5.5.9. South Africa Market Size And Forecast, Distribution Channel
7.5.5.11. Rest Of Lamea Market Size And Forecast, By Application
7.5.5.12. Rest Of Lamea Market Size And Forecast, By Route Of Administration
7.5.5.13. Rest Of Lamea Market Size And Forecast, Distribution Channel
Chapter 8: Company Profiles
8.1. Novo Nordisk
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.2. Merck & Co.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.3. Eli Lilly And Company.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance
8.4. Pfizer Inc.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.5. Teva Pharmaceutical Industries.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.6. Novartis Ag
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.7. Anhui Anke Biotechnology (Group) Co., Ltd.
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.8. Roche
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.9. Ipsen
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Ferring Bv
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
Trends Market Research © Copyright 2020. All Rights Reserved.
